Hugo Ong

Hugo Ong is a seasoned professional in finance and investor relations, currently serving as Senior Manager of Investor Relations and FP&A at 4D Molecular Therapeutics since May 2023. Previous roles include Senior Director of Corporate Business Analyst at Instil Bio, Analyst in Biotechnology at Ashler Capital, and Vice President in both Analyst/Associate Portfolio Manager positions at Allianz Global Investors and Equity Research in Biotechnology at Jefferies. Hugo Ong also worked as a Research Associate Analyst at Natixis Bleichroeder, LLC, and as a Graduate Research Assistant at the University of Illinois at Urbana-Champaign. Educational qualifications include a Ph.D. in Organic Chemistry from the University of Illinois Urbana-Champaign and a B.A/B.S. in Chemistry and Biological Sciences from Northern Kentucky University.